双基因BCKDHA-BCKDHB疗法在两种小鼠模型和一头经典枫糖尿症犊牛中恢复代谢稳态
经典枫糖尿症由BCKDH复合体E1α/β亚基双等位基因突变所致,仅靠严格处方饮食或肝移植管理。研究设计双功能rAAV9载体递送密码子优化的BCKDHA与BCKDHB至肝、肌、心、脑,在两种严重MSUD小鼠模型和一头BCKDHA c.248C>T纯合新生犊牛中,单次出生后注射防止围产期死亡、恢复正常生长、恢复多组织BCKDHA与BCKDHB协调表达,并在高蛋白摄入下稳定MSUD生物标志物。
要点
- rAAV9.hA-BiP-hB在细胞中恢复BCKDHA与BCKDHB共表达及BCKDH全酶活性。
- 野生型小鼠系统给药2.7×10^14 vg/kg未扰动生理支链氨基酸稳态。
- 两种严重MSUD小鼠模型及一头纯合犊牛单次注射后防止围产期死亡并恢复正常生长。
核心结论
- 研究开发了一次性BCKDHA-BCKDHB系统双基因替代策略,有望成为经典MSUD 1A型和1B型处方饮食与肝移植的治疗替代方案。
研究设计与样本
- 研究设计双功能重组腺相关病毒血清型9(rAAV9)载体rAAV9.hA-BiP-hB,递送密码子优化的BCKDHA和BCKDHB至肝、肌、心、脑。
- 在BCKDHA-/- HEK293T细胞、野生型小鼠、两种严重MSUD小鼠模型(Bckdha-/-和Bckdhb-/-)及一头BCKDHA c.248C>T纯合新生犊牛中评价。
主要发现
- rAAV9.hA-BiP-hB在BCKDHA-/- HEK293T细胞中恢复BCKDHA与BCKDHB共表达及BCKDH全酶活性。
- 野生型小鼠系统给药2.7×10^14 vg/kg未扰动生理支链氨基酸稳态。
- 两种严重MSUD小鼠模型及一头纯合犊牛单次出生后注射防止围产期死亡、恢复正常生长。
- 单次注射恢复骨骼肌、肝、心、脑BCKDHA与BCKDHB协调表达,并在高蛋白摄入下稳定MSUD生物标志物。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Classic maple syrup urine disease (MSUD) results from biallelic mutations in genes that encode the branched-chain α-ketoacid dehydrogenase E1α (BCKDHA), E1β (BCKDHB), or dihydrolipoamide branched-chain transacylase (DBT) subunits, which interact to form the mitochondrial BCKDH complex that decarboxylates ketoacid derivatives of leucine, isoleucine, and valine. MSUD is an inborn error of metabolism characterized by recurrent life-threatening neurologic crises and progressive brain injury that can only be managed with an exacting prescription diet or allogeneic liver transplant. To develop a gene replacement therapy for MSUD, we designed a dual-function recombinant adeno-associated virus serotype 9 (rAAV9) vector to deliver codon-optimized BCKDHA and BCKDHB (rAAV9.hA-BiP-hB) to the liver, muscle, heart, and brain. rAAV9.hA-BiP-hB restored coexpression of BCKDHA and BCKDHB as well as BCKDH holoenzyme activity in BCKDHA-/- HEK293T cells and did not perturb physiologic branched-chain amino acid homeostasis in wild-type mice at a systemic dose of 2.7 × 1014 vector genomes per kilogram. In two models of severe MSUD (Bckdha-/- and Bckdhb-/- mice) and a newborn calf homozygous for BCKDHA c.248C>T, one postnatal injection prevented perinatal death, normalized growth, restored coordinated expression of BCKDHA and BCKDHB in the skeletal muscle, liver, heart, and brain, and stabilized MSUD biomarkers in the face of high protein ingestion. In summary, we developed a one-time BCKDHA-BCKDHB systemic dual-gene replacement strategy that holds promise as a therapeutic alternative to prescription diet and liver transplant for treatment of MSUD types 1A and 1B, the two most common forms of MSUD in humans.
引用
- Wang J, Poskitt LE, Gallagher J, et al. BCKDHA-BCKDHB digenic gene therapy restores metabolic homeostasis in two mouse models and a calf with classic maple syrup urine disease. Sci Transl Med. 2025. PMID: 40009698. doi:10.1126/scitranslmed.ads0539
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。